Lexeo Therapeutics, Inc. (LXEO) Return on Sales (2022 - 2023)
Lexeo Therapeutics' Return on Sales history spans 2 years, with the latest figure at 283.74% for Q4 2023.
- For Q4 2023, Return on Sales changed N/A year-over-year to 283.74%; the TTM value through Dec 2023 reached 323.87%, changed N/A, while the annual FY2024 figure was 717.76%, 39389.0% up from the prior year.
- Return on Sales for Q4 2023 was 283.74% at Lexeo Therapeutics, down from 386.71% in the prior quarter.
- Across five years, Return on Sales topped out at 386.71% in Q3 2023 and bottomed at 32.12% in Q3 2022.